Source link : https://www.newshealth.biz/health-news/long-term-budesonide-shows-sustained-efficacy-in-eoe/
TOPLINE: Budesonide orodispersible tablets (BOTs) maintain remission and improve quality of life (QOL) in a majority of adults with eosinophilic esophagitis (EoE) for up to 144 weeks. METHODOLOGY: There is an urgent need for long-term data on medical therapeutics in EoE, given that patients with this chronic condition often experience relapse after treatment discontinuation. Researchers […]
Author : News Health
Publish date : 2025-01-10 08:31:38
Copyright for syndicated content belongs to the linked Source.